Cost-Effectiveness of Individualized Occupational Therapy for Inpatients With Schizophrenia: Two-Year Follow-Up of a Multicenter Randomized Controlled Trial
American Journal of Occupational Therapy · 2026
DOI: 10.5014/ajot.2026.051323 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Occupational Therapy, 2026. Verfasst von Hirofumi Nagayama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hirofumi Nagayama, OT, PhD, is Associate Professor, Department of Occupational Therapy, Kanagawa University of Human Services, Yokosuka, Japan, and C…. Hauptthemen laut MEDLINE: Schizophrenia, Occupational Therapy. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Importance: Schizophrenia typically requires long-term treatment, making cost-effective interventions essential, yet the cost-effectiveness of individualized occupational therapy (IOT) remains unclear.
Objective
To compare the cost-effectiveness of IOT plus group occupational therapy (GOT) with GOT alone for inpatients with schizophrenia over 2 yr.
Design
Secondary analysis of data from a multicenter, two-arm, parallel randomized controlled trial.
Setting
Fourteen clinical facilities.
Participants
Sixty-two inpatients with schizophrenia who completed 2-yr follow-up.
Intervention
GOT alone or IOT+GOT during 3 mo of hospitalization. Outcomes and Measures: Quality-adjusted life-years (QALYs) and total medical costs from a health care payer perspective over 2 yr.
Results
Compared with GOT alone ( n = 30), IOT+GOT ( n = 32) produced greater cumulative QALYs ( M difference = 0.156) and lower total medical costs ( M difference = −¥290,784). The incremental cost-effectiveness ratio was −¥3,304,420 per QALY gained. Incremental net benefit was positive at willingness-to-pay thresholds of ¥5,000,000 and ¥6,000,000 per QALY. The cost-effectiveness acceptability curves showed a 94.2% probability of cost-effectiveness at a threshold of ¥6,000,000. Cost data were complete for approximately 40% of participants; missingness was addressed using multiple imputation, with complete-case sensitivity analysis yielding directionally consistent findings. Conclusions and Relevance: IOT+GOT was more cost-effective than GOT alone over 2 yr, supporting its wider adoption as an economically sound rehabilitation strategy for clients with schizophrenia. Given the extent of missing cost data, the results should be interpreted with appropriate caution. These findings offer long-term economic evidence to inform mental health policies and resource allocation in psychiatric care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Hirofumi Nagayama, OT, PhD, is Associate Professor, Department of Occupational Therapy, Kanagawa University of Human Services, Yokosuka, Japan, and Committee Member, Scientific Department, Japanese Association of Occupa…
- Takeshi Shimada, OT, PhD, is Committee Member, Scientific Department, Japanese Association of Occupational Therapists, Tokyo, Japan, and Occupational Therapist, Medical Corporation Yuaikai, Tikumaso Mental Hospital, Nag…
- Takafumi Morimoto, OT, PhD, is Associate Professor, Department of Occupational Therapy, School of Health Sciences, Sapporo Medical University, Sapporo, Japan.
- Kohei Ikeda, OT, PhD, is Lecturer, Department of Occupational Therapy, Kanagawa University of Human Services, Yokosuka, Japan.
- Masayoshi Kobayashi, OT, PhD, is Professor, Department of Health Sciences, Shinshu University, Nagano, Japan.
Zitieren
APA
Nagayama, H., Shimada, T., Morimoto, T., Ikeda, K., & Kobayashi, M. (2026). Cost-Effectiveness of Individualized Occupational Therapy for Inpatients With Schizophrenia: Two-Year Follow-Up of a Multicenter Randomized Controlled Trial. American Journal of Occupational Therapy. https://doi.org/10.5014/ajot.2026.051323
Vancouver
Nagayama H, Shimada T, Morimoto T, Ikeda K, Kobayashi M. Cost-Effectiveness of Individualized Occupational Therapy for Inpatients With Schizophrenia: Two-Year Follow-Up of a Multicenter Randomized Controlled Trial. American Journal of Occupational Therapy. 2026. doi:10.5014/ajot.2026.051323
BibTeX
@article{Nagayama2026,
author = {Nagayama, Hirofumi and Shimada, Takeshi and Morimoto, Takafumi and Ikeda, Kohei and Kobayashi, Masayoshi},
title = {Cost-Effectiveness of Individualized Occupational Therapy for Inpatients With Schizophrenia: Two-Year Follow-Up of a Multicenter Randomized Controlled Trial},
journal = {American Journal of Occupational Therapy},
year = {2026},
doi = {10.5014/ajot.2026.051323}
}
EUVIMED